India is again facing a concerning but seemingly controlled increase in Covid-19 cases. As of June 13, 2025, the active case count of the country is 7,131, as per the Ministry of Health and Family Welfare. Although new daily cases increased by 33 and three more deaths were added—two in Maharashtra and one in Madhya Pradesh—the overall trend indicates a potential plateau and even a slight dip, which gives optimistic hopes.

The most recent state-by-state Covid-19 dashboard published by the Ministry of Health and Family Welfare indicates remarkable regional variations in infection incidence in India. Kerala remains to have the highest burden, with 2,055 active cases, out of which 110 were new cases in one day. Gujarat is the second worst-affected state with 1,358 active cases, which saw a steep daily jump of 77 cases. Other majorly affected states are West Bengal, with 747 active cases; Delhi, with 714 cases; and Maharashtra, with 629 active infections. The Karnataka region showed a significant increase with 72 new cases, taking its active caseload to 395. On the other hand, there are no active Covid-19 cases in certain states like Arunachal Pradesh, Mizoram, and Manipur, hinting at effective containment measures. In spite of these diverse regional numbers, the overall national trend seems positively tentative. There were 1,420 new recoveries logged, elevating the total number of recovered or migrated persons to 10,976 for the year, which highlights India's resilience in its continuous Covid-19 response.

The increase is credited mainly to new Omicron sub-variants, such as JN.1, LF.7, NB.1.8.1, and XFG, which are highly contagious but produce milder symptoms than previous strains. These variants are now listed as "Variants Under Monitoring" by the World Health Organization (WHO). While not yet classified as variants of concern, they necessitate heightened vigilance, particularly among high-risk groups.

Experts advise against attributing these numbers to the onset of a full-blown wave. Rather, they refer to a seasonal surge, similar to the flu, which is consonant with the virus's post-pandemic shift towards an endemic pattern.

Why Are Booster Shots Not Recommended?

In light of India's high hybrid immunity from both vaccinations and past infections, health authorities as of now not recommending mass booster drives. Rather, targeted vaccination is being encouraged for:

• The elderly
• Immunocompromised hosts
• People with chronic respiratory or cardiovascular disease

The Indian Medical Association and health professionals emphasize that this risk-based, strategic strategy is more effective protection than mass immunization campaigns.

Even with the recent upsurge, health workers urge not panicking but remaining proactive. Distinguishing between Covid-19 and other common seasonal viral infections—often producing the same symptoms as fever, fatigue, and cough—is now of paramount importance.

Physicians and public health specialist, point out that exhaustion from sustained lookout can precipitate complacency. We can't ignore Covid-19 as a historical moment. It's very much still around—but controlled with the appropriate preventive measures.

Actionable Tips To Prevent COVID Infection

Nowadays, personal responsibility and daily routine are still your best protection. Here's how to protect yourself:

1. Wear a Mask in Crowded Indoor Spaces

Though mandates may have disappeared, masks are effective, especially in poorly ventilated spaces indoors, on public transportation, and in medical offices.

2. Get Current with Targeted Vaccines

If you are in a high-risk group, speak with your health care provider about boosters that are available or trials soon to be under way for new variant-specific vaccines.

3. Boost Your Immune System

Prioritize a balanced diet, proper sleep, and regular physical activity in order to maintain your immune system strong against not only Covid-19 but also other flu and seasonal diseases.

4. Practice Hygiene

Good hygiene habits such as regular handwashing, the use of sanitizers, and not touching your face while in public can significantly minimize the risk of transmission.

5. Stay Away from Crowds

If you are symptomatic—or have someone living with you who is—skip gatherings and go remote work whenever possible.

6. Identify Symptoms Early

Notice signs such as fever, chronic cough, body pain, fatigue, and taste/smell loss. Test early and self-isolate to avoid transmission.

7. Seek Medical Help

Particularly if above 60 years or with underlying conditions, don't wait even for minor symptoms. Early treatment can be life-saving.

The India Covid-19 situation is serious but under control. Yes, the active cases are more than 7,100, but the recovery rates are robust, and the fatalities are few and limited to the vulnerable groups.

Instead of fear, this time it requires a recommitment to public health practices—from mask-wearing when necessary to symptom-watching and protecting the vulnerable.

Key Figures at a Glance (as of June 13, 2025)

Total Active Cases: 7,131

New Cases in 24 Hours: 33

Total Deaths (2025): 78

Top States by Active Cases: Kerala (2055), Gujarat (1358), West Bengal (747), Delhi (714), Maharashtra (629)

Recovered in 2025: 10,976 and rising

Death IN Last 24 Hours: 1 (Kerala)

The Uttar Pradesh Government today announced a partnership with Wadhwani AI to develop a roadmap for deploying a suite of AI-powered solutions across the state’s public health programs.

The partnership will advance the deployment of seven AI-powered solutions, such as:

• tuberculosis care and management

• telemedicine

• eye health

• maternal and child health

• equipping frontline health workers with data-driven tools

Wadhwani AI will serve as a technical partner to the state, supporting the deployment of AI-driven tools aligned with the government’s public health priorities.

The collaboration aligns with the UP AI Mission -- a three-year initiative launched by the UP Government to build a state-led AI ecosystem and accelerate the use of AI across sectors, including governance, healthcare, and agriculture.

“AI offers a promising opportunity to further enhance efforts by supporting frontline health workers, improving early disease detection, and enabling more informed clinical decision-making,” said Amit Kumar Ghosh (IAS), Additional Chief Secretary, Medical Health, Family Welfare, and Medical Education in Uttar Pradesh.

“Through this partnership with Wadhwani AI, we look forward to adopting and deploying AI-driven tools across our health programs and progressively expanding the use of these solutions to further strengthen service delivery and improve health outcomes across the state,” Ghosh added.

The AI-powered Solutions

• In tuberculosis care, the Cough Against TB (CATB) mobile phone-based screening application will enable frontline healthcare workers to identify individuals with presumptive pulmonary TB by analyzing cough sounds and accompanying symptoms, enabling early detection even in community settings.

Vulnerability Mapping for Tuberculosis (VMTB) will use geospatial AI analytics to identify high-risk locations by analyzing TB program data alongside multiple environmental and health indicators, helping health authorities prioritize targeted interventions and active case-finding activities.

The Prediction of Adverse TB Outcomes (PATO), an AI-powered risk stratification tool, will help identify patients at higher risk of adverse outcomes at the onset of TB treatment and facilitate prompt, targeted, and effective interventions that, over time, will help lower mortality rates and prevent drug-resistant TB.

• In telemedicine, the Clinical Decision Support System (CDSS) will enable clinicians to access structured patient information and offer AI-assisted differential diagnosis recommendations during consultations, supporting the quality and consistency of care delivery across primary healthcare settings.

• The collaboration will also include the deployment of Health Vaani, a voice- and text-based knowledge assistant which will provide frontline health workers with instant access to government-approved health guidelines, enabling quicker decision-making and more consistent service delivery at the community level.

• To address the growing burden of diabetes-related vision complications, the partnership will also deploy MadhuNetrAI, an AI-enabled screening solution that will analyze retinal images to detect diabetic retinopathy and support early referral for specialist care, particularly in resource-constrained settings where specialist availability may be limited.

• In maternal and newborn health, Shishu Maapan, an AI-powered newborn anthropometry tool, will enable frontline health workers to capture accurate newborn measurements using a smartphone during home-based newborn care visits.

“The solutions being deployed span the continuum of health delivery from identifying high-risk communities to supporting ASHA workers during field visits, to enabling early disease detection through AI-assisted analysis,” said Dr. Neeraj Agrawal, Chief Program Officer, Wadhwani AI.

"As the partnership progresses, we look forward to expanding this work and supporting additional AI solutions that can further strengthen health systems and improve outcomes at scale," he added.

Antibiotics have long been considered lifesaving medicines, especially when it comes to treating serious bacterial infections. However, scientists have also known for years that these drugs can disturb the gut microbiome, the vast community of bacteria that live in our digestive system and play an important role in overall health. Now, new research suggests that the impact of some antibiotics on the gut may last far longer than previously believed.

A recent study has found that certain antibiotics may alter the gut microbiome in ways that persist for up to four to eight years after treatment. The findings were reported by scientists from Sweden and published in the journal Nature Medicine. According to the researchers, these long lasting changes may reduce the diversity of bacteria in the gut, which could potentially influence health over time.

Long term changes in gut bacteria

The gut microbiome contains hundreds of different species of bacteria that help regulate digestion, immunity, metabolism and even aspects of mental health. A healthy gut microbiome usually has a wide variety of bacterial species. When this diversity decreases, it may make the body more vulnerable to several health conditions.

Scientists have previously linked lower microbial diversity in the gut to problems such as obesity, diabetes and inflammatory bowel disease. Because antibiotics kill bacteria to fight infections, they may also eliminate beneficial microbes along with harmful ones. In some cases, this imbalance may take a long time to recover.

In the new study, researchers identified specific antibiotics that appeared to have the strongest and most lasting effects on gut bacteria. These included clindamycin, fluoroquinolones and flucloxacillin. The study’s lead investigator said that these medications were associated with significant changes in the overall composition of the gut microbiome.

Researchers observed that some bacterial species declined after antibiotic exposure while others increased. This shift altered the balance of the microbial community and was linked to reduced diversity.

Comparing antibiotic users and non users

To understand the relationship between antibiotics and gut bacteria, the research team analysed data from Sweden’s National Prescribed Drug Register. They then compared this information with gut microbiome samples from 14,979 adults living in Sweden.

The scientists examined the microbiome of people who had been prescribed different antibiotics and compared it with those who had not received any antibiotics during the same period.

Their analysis revealed that some antibiotics had stronger long term effects than others. For instance, penicillin V, one of the most commonly prescribed antibiotics for infections outside hospitals in Sweden, appeared to cause shorter lasting changes in gut bacteria.

However, other antibiotics were linked to more persistent shifts in the microbial ecosystem.

Effects that last for years

One of the most striking findings of the study was how long the effects could remain visible. According to the researchers, antibiotic use from four to eight years earlier was still associated with differences in a person’s gut microbiome.

Even a single course of certain antibiotics appeared to leave detectable traces years later. While the exact biological mechanisms are still not fully understood, the researchers believe antibiotics may permanently reshape parts of the microbial community in some individuals.

What this means for future antibiotic use

The researchers believe their findings could help guide future decisions about prescribing antibiotics. If two antibiotics are equally effective against an infection, doctors may eventually consider choosing the one that has a weaker impact on the gut microbiome.

Such insights could help balance the need to treat infections while also protecting long term gut health.

To better understand how the microbiome recovers over time, the scientists are now collecting a second set of gut samples from nearly half of the participants involved in the study. This follow up analysis may reveal how quickly the microbiome can recover after antibiotic exposure and which individuals may be more vulnerable to long lasting disruptions.

A Food and Drug Administration (FDA) advisory committee on Thursday voted to recommend a new strain of flu in its vaccines for fall. This viral strain of flu is called subclade k.

The World Health Organization (WHO) also suggested that the variant is likely one reason flu vaccines were less effective this year. The Centers for Disease Control and Prevention in its Morbidity and Mortality Weekly Report (MMWR) noted that influenza vaccine effectiveness was 38 per cent to 41 per cent for preventing outpatient visits for children and adolescents and 41 per cent for preventing hospitalization.

For adults, the number was between 22 per cent to 34 per cent against influenza-associated outpatient visits and 30 per cent against influenza-associated hospitalization.

Although the figures were lower than those seen in recent flu seasons, the CDC emphasized that influenza vaccines still offer meaningful protection and continues to recommend vaccination. Last year alone, flu shots helped prevent around 5 million medical visits, 180,000 hospitalizations, and 12,000 deaths.

According to CDC estimates, influenza caused at least 26 million illnesses, 340,000 hospitalizations, and 21,000 deaths between October 1 and February 28.

At the committee meeting, Dr. Lisa Grohskopf, a medical officer in the CDC’s Influenza Division, noted that subclade K is currently the dominant flu variant circulating in the Northern Hemisphere.

However, the University of Minnesota’s Center for Infectious Disease Research and Policy highlighted that flu viruses mutate frequently. This means there is no certainty that the strains chosen now will be the ones circulating in the next flu season. Since vaccine production takes roughly six months, scientists must finalize the formulation as early as February or March.

Arnold Monto, an epidemiologist at the University of Michigan and acting chair of the Vaccines and Related Biological Products Advisory Committee, acknowledged the challenge, noting that selecting the right strains involves “a little bit of science and a little bit of luck,” according to Politico.

What Is Subclade K?

Known as the superfly, this is H3N2 'subclade K'. It is a type of seasonal influenza A virus and people have not encountered much of it in the recent years. This is why there is less immunity against it. However, the National Health Service (NHS), UK, has already sent out a 'flu jab SOS' to vulnerable people.

Daniel Elkeles, chief executive of NHS Providers, said that the major concern is that H3N2 is associated with a more severe illness and superflu could be "a very nasty strain of flu". He said that UK could be experiencing a "tidal wave" of illness.

The main strain circulating this winter is a drifted H3N2 variant, which the UKHSA says has left the community with “less natural immunity.” H3N2 strains tend to cause more serious illness in older adults than H1N1 strains and are linked to higher hospitalizations and deaths. This pattern adds further strain to the NHS during the winter months.